Denali Therapeutics (DNLI) Stock
Denali Therapeutics (DNLI) closed at $18.74 on Nov 13, 2026; its Tenet Score is 53 of 100 against 409 Healthcare peers.
30 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $18.74
- Nov 13, 2026
- Market cap
- $3.0B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 15.34 – 27.30
- low → high
- Tenet Score
- 53/100
- Mixed · 409 Healthcare peers
Industry: Drugs · see every company filed here →
Denali Therapeutics Inc scores 53/100. Mixed. Strongest on financial health, quality is the soft spot versus 409 Healthcare peers. Insufficient inputs: Tenet 53 is built from 3 of 4 pillars, from 35% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=409Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ~ Drawdown Context
- ✕ Reversal Evidence
- ~ Not-a-Value-Trap Gate
13F flows & insider trades land here.
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Indivior Pharmaceuticals Inc.INDV | 51 | $3.5B |
| Supernus Inc.SUPN | 47 | $3.5B |
| Acadia Pharmaceuticals IncACAD | 64 | $3.2B |
| Dyne Therapeutics IncDYN | 52 | $3.2B |
| Bausch Health Companies IncBHC | 50 | $3.1B |
| Ideaya Biosciences IncIDYA | 62 | $3.1B |
| Xeris Biopharma Holdings IncXERS | 44 | $3.0B |
| Adma Biologics IncADMA | 67 | $3.0B |
| Vericel CorpVCEL | 59 | $2.9B |
| Xencor IncXNCR | 41 | $2.8B |
Common questions
What sector and industry is Denali Therapeutics in?
Denali Therapeutics is in the Healthcare sector and the Drugs industry.
What is Denali Therapeutics' Tenet Score?
Denali Therapeutics' Tenet Score is 53 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




